Global Dog Vaccines Market Size Study, by Vaccine Type, by Disease Type, by Route of Administration, by Duration of Immunity, by Component, and Regional Forecasts 2022-2032

Description

Global Dog Vaccines Market is valued at approximately USD 1.87 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.45% over the forecast period 2024-2032. The Dog Vaccines market plays a pivotal role in ensuring the health and safety of canines worldwide. It is underpinned by robust advancements in veterinary science, focusing on disease prevention through targeted immunization protocols. Vaccination programs have evolved to include a diverse array of vaccine types tailored to address specific canine diseases, thereby fostering greater protection for both pets and working dogs. This sector's growth is driven by heightened awareness among pet owners, increased adoption of pets, and stringent government mandates on pet vaccination in various countries.

The escalating incidence of zoonotic diseases and the surge in pet ownership globally are catalyzing the demand for dog vaccines. For instance, the increasing prevalence of canine rabies-a fatal disease that continues to pose a threat in many developing regions-underscores the critical need for effective vaccination strategies. Additionally, innovative vaccine technologies, such as recombinant vaccines, have introduced safer and more efficient immunization solutions. However, the high costs associated with vaccine development and distribution and the lack of awareness about canine health in underdeveloped areas may hinder market growth.

The market is further bolstered by advancements in veterinary healthcare infrastructure and the ongoing efforts by governments and private entities to control and eliminate life-threatening canine diseases. Notably, several initiatives focus on increasing access to affordable vaccines in rural and underserved regions, thereby fostering equitable healthcare outcomes for canine populations. Moreover, the growing trend towards combined vaccines that offer protection against multiple diseases in a single dose is reshaping the market dynamics, enhancing convenience for pet owners and veterinary practitioners alike.

Key regions considered for the global Dog Vaccines market study include North America, Europe, Asia Pacific, Latin America, and the Rest of the World. In 2023, North America dominated the market, driven by well-established veterinary healthcare systems, a high prevalence of pet ownership, and stringent vaccination regulations. Europe follows closely, with a strong focus on research and development, coupled with supportive government initiatives aimed at disease control. Meanwhile, the Asia Pacific region is projected to witness the fastest growth during the forecast period, propelled by rising disposable incomes, increased awareness of pet health, and significant investments in veterinary infrastructure.

Major market players included in this report are:

Zoetis Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health Incorporated
Virbac S.A.
Ceva Sante Animale
Phibro Animal Health Corporation
Vetoquinol S.A.
Indian Immunologicals Ltd.
HIPRA
Neogen Corporation
Bayer Animal Health GmbH
Bimeda, Inc.
IDT Biologika GmbH
Hester Biosciences Limited

The detailed segments and sub-segment of the market are explained below:

By Vaccine Type:

Modified/Attenuated Live
Inactivated
Other Vaccines

By Disease Type:

Canine Distemper
Canine Infectious Respiratory Disease Complex (CIRDC)
Canine Parvovirosis/Parvovirus Disease
Canine Leptospirosis
Canine Lyme Disease
Infectious Canine Hepatitis
Canine Rabies

By Route of Administration:

Injectables
Oral
Intranasal

By Duration of Immunity:

1 Year
3 Year
Others

By Component:

Combined Vaccines
Mono Vaccines

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
Rest of Europe

Asia Pacific:

China
India
Japan
Australia
South Korea
Rest of Asia Pacific

Latin America:

Brazil
Mexico
Rest of Latin America

Middle East & Africa:

Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study:

Historical Year: 2022
Base Year: 2023
Forecast Period: 2024-2032

Key Takeaways:

Market Estimates & Forecasts for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Dog Vaccines Market Executive Summary

1.1. Global Dog Vaccines Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Vaccine Type
- 1.3.2. By Disease Type
- 1.3.3. By Route of Administration
- 1.3.4. By Duration of Immunity
- 1.3.5. By Component
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Dog Vaccines Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Dog Vaccines Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Prevalence of Zoonotic Diseases
- 3.1.2. Rise in Pet Ownership and Humanization of Pets
- 3.1.3. Advancements in Vaccine Technologies
3.2. Market Challenges
- 3.2.1. High R&D and Distribution Costs
- 3.2.2. Limited Veterinary Services in Emerging Markets
3.3. Market Opportunities
- 3.3.1. Expansion of Veterinary Healthcare Infrastructure
- 3.3.2. Development of Combined Vaccines
- 3.3.3. Government Initiatives for Disease Control

Chapter 4. Global Dog Vaccines Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Dog Vaccines Market Size & Forecasts by Vaccine Type 2022-2032

5.1. Segment Dashboard
5.2. Global Dog Vaccines Market: Vaccine Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Modified/Attenuated Live
- 5.2.2. Inactivated
- 5.2.3. Other Vaccines

Chapter 6. Global Dog Vaccines Market Size & Forecasts by Disease Type 2022-2032

6.1. Segment Dashboard
6.2. Global Dog Vaccines Market: Disease Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Canine Distemper
- 6.2.2. Canine Infectious Respiratory Disease Complex (CIRDC)
- 6.2.3. Canine Parvovirosis/Parvovirus Disease
- 6.2.4. Canine Leptospirosis
- 6.2.5. Canine Lyme Disease
- 6.2.6. Infectious Canine Hepatitis
- 6.2.7. Canine Rabies

Chapter 7. Global Dog Vaccines Market Size & Forecasts by Region 2022-2032

7.1. North America Dog Vaccines Market
- 7.1.1. U.S. Dog Vaccines Market
  - 7.1.1.1. Vaccine Type Breakdown Size & Forecasts, 2022-2032
  - 7.1.1.2. Disease Type Breakdown Size & Forecasts, 2022-2032
- 7.1.2. Canada Dog Vaccines Market
  - 7.1.2.1. Vaccine Type Breakdown Size & Forecasts, 2022-2032
  - 7.1.2.2. Disease Type Breakdown Size & Forecasts, 2022-2032
7.2. Europe Dog Vaccines Market
- 7.2.1. UK Dog Vaccines Market
- 7.2.2. Germany Dog Vaccines Market
- 7.2.3. France Dog Vaccines Market
- 7.2.4. Spain Dog Vaccines Market
- 7.2.5. Italy Dog Vaccines Market
- 7.2.6. Rest of Europe Dog Vaccines Market
7.3. Asia-Pacific Dog Vaccines Market
- 7.3.1. China Dog Vaccines Market
- 7.3.2. India Dog Vaccines Market
- 7.3.3. Japan Dog Vaccines Market
- 7.3.4. Australia Dog Vaccines Market
- 7.3.5. South Korea Dog Vaccines Market
- 7.3.6. Rest of Asia Pacific Dog Vaccines Market
7.4. Latin America Dog Vaccines Market
- 7.4.1. Brazil Dog Vaccines Market
- 7.4.2. Mexico Dog Vaccines Market
- 7.4.3. Rest of Latin America Dog Vaccines Market
7.5. Middle East & Africa Dog Vaccines Market
- 7.5.1. Saudi Arabia Dog Vaccines Market
- 7.5.2. South Africa Dog Vaccines Market
- 7.5.3. Rest of Middle East & Africa Dog Vaccines Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Zoetis Inc.
- 8.1.2. Merck & Co., Inc.
- 8.1.3. Boehringer Ingelheim International GmbH
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Zoetis Inc.
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. Merck & Co., Inc.
- 8.3.3. Boehringer Ingelheim International GmbH
- 8.3.4. Elanco Animal Health Incorporated
- 8.3.5. Virbac S.A.
- 8.3.6. Ceva Sante Animale
- 8.3.7. Phibro Animal Health Corporation
- 8.3.8. Vetoquinol S.A.
- 8.3.9. Indian Immunologicals Ltd.
- 8.3.10. HIPRA
- 8.3.11. Neogen Corporation
- 8.3.12. Bayer Animal Health GmbH
- 8.3.13. Bimeda, Inc.
- 8.3.14. IDT Biologika GmbH
- 8.3.15. Hester Biosciences Limited

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes